<DOC>
	<DOCNO>NCT01758874</DOCNO>
	<brief_summary>PAD cause increase flow resistance atherosclerotic ischemic limb . The investigator hypothesize reduce blood viscosity ( controlled phlebotomy ) , thereby increase deformability red blood cell , reduce flow resistance improve tissue perfusion lead improved clinical function reduction symptom . Preliminary data demonstrate phlebotomy cause measurable change blood viscosity measure home-made rheologic method . To evaluate effectiveness change blood viscosity , obtain control phlebotomy , therapy improve functional status associate atherosclerotic ischemic limb pre-amputation patient .</brief_summary>
	<brief_title>Study Explore Effect Lowering Blood Viscosity Patients With Treatment-resistant Critical Limb Ischemia</brief_title>
	<detailed_description>The first study pilot study act proof principle . This first study include 20 patient divide 2 group basis randomize control trial : 10 patient control group receive conventional treatment 10 patient receive therapeutic phlebotomy lower blood viscosity . The objective evaluate effect control phlebotomy patient Grade 3 , Category 5 6 chronic critical limb ischemia tissue loss Rutherford classification ( Fontaine stage IV ) , end-stage peripheral vascular disease resistant maximal medical therapy revascularization therapy ( percutaneous surgical ) either proved insufficient contra-indicated decline patient , usually result amputation . The primary outcome parameter : salvage rate limb compare salvage rate limb conventional therapy . Objective classification improvement perfusion distal extremity use ankle-brachial index ( ABI ) , visual analogue pain scale , photo . Subjective classification improvement pain scale critical limb . The relationship alteration outcome parameter ( i.e. , end point reduce amputation rate ) blood viscosity evaluate measured home-made rheologic method .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Subjects diagnose Rutherford classification Grade 3 , Category 5 6 ( Fontaine stage IV ) treatmentresistant chronic critical limb ischemia tissue loss , relieve maximal medical therapy exhaust candidate surgical ( heart transplant ) percutaneous intervention Male Age : 18 80 year Current nonsmoker BMI &gt; 19 Estimated 6 month survival rate &gt; 90 % Concomitant stable medication allow . If subject coronary artery disease establish history , angina pain , EKG , Lab include Troponin I , creatine kinase , lactate dehydrogenase , Echocardiography , Thallium scan coronary angiography , subject establish classification coronary artery involvement coronary angiography procedure similar precision . Anemia Low blood pressure ( systolic &lt; 120 mmHg ) Baseline hematocrit &lt; 30 Initial whole blood viscosity measurement 15 miliPoiseille</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Critical limb ischemia</keyword>
	<keyword>Phlebotomy</keyword>
	<keyword>Amputation</keyword>
	<keyword>Rutherford classification Grade 3 , Category 5 6</keyword>
	<keyword>Fontaine stage IV</keyword>
</DOC>